Hepatitis B virus
Hepatitis B virus
03-08-2018 | HBV | News | Article
HCC risk remains even after achieving positive HBV outcomes
Two meta-analyses published in the Journal of Viral Hepatitis confirm that patients with hepatitis B virus infection remain at risk for hepatocellular carcinoma even after achieving positive virologic outcomes, and identify factors associated with the risk.
03-08-2018 | HBV | News | Article
Global HBV prevalence estimated at 3.9%
More than 290 million people, or 3.9% of the global population, are infected with hepatitis B virus, and while efforts to combat infection are improving, greater access to diagnosis and treatment is needed to meet global targets, report The Polaris Observatory Collaborators.
03-05-2018 | HBV | News | Article
End of treatment HBsAg levels may predict HBV relapse
Hepatitis B surface antigen levels at the end of treatment or prophylaxis with nucleos(t)ide analog inhibitors could be a useful indicator of hepatitis B virus relapse, suggest two Taiwanese studies.
01-02-2018 | HBV | News | Article
Estimates of HBV carrier numbers in Japan released
Japanese researchers have generated a nationwide estimate of total numbers of hepatitis B virus carriers and treated patients in 2011, comparing it with earlier estimates from 2000.
22-12-2017 | HBV | News | Article
FIB-4 index identifies chronic HBV patients with lowest HCC risk
The noninvasive fibrosis-4 index can further refine the existing favorable clinical profile for hepatocellular carcinoma risk in noncirrhotic patients with chronic hepatitis B virus infection and help identify those with the lowest risk, say researchers.
29-09-2017 | HBV | News | Article
Novel indices to diagnose fibrosis in chronic HBV patients developed
Two research groups have developed noninvasive indices to detect significant fibrosis in treatment-naïve patients with chronic hepatitis B virus infection, one using serum levels of Golgi protein 73 and liver stiffness, and the other based on the ratio of gamma-glutamyl transpeptidase to albumin.